Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 1/2012

01.01.2012 | Guidelines

Proposal for the standardisation of multi-centre trials in nuclear medicine imaging: prerequisites for a European 123I-FP-CIT SPECT database

verfasst von: John Caddell Dickson, Livia Tossici-Bolt, Terez Sera, Robin de Nijs, Jan Booij, Maria Claudia Bagnara, Anita Seese, Pierre Malick Koulibaly, Umit Ozgur Akdemir, Cathrine Jonsson, Michel Koole, Maria Raith, Markus Nowak Lonsdale, Jean George, Felicia Zito, Klaus Tatsch

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Multi-centre trials are an important part of proving the efficacy of procedures, drugs and interventions. Imaging components in such trials are becoming increasingly common; however, without sufficient control measures the usefulness of these data can be compromised. This paper describes a framework for performing high-quality multi-centre trials with single photon emission computed tomography (SPECT), using a pan-European initiative to acquire a normal control dopamine transporter brain scan database as an example.

Methods

A framework to produce high-quality and consistent SPECT imaging data was based on three key areas: quality assurance, the imaging protocol and system characterisation. Quality assurance was important to ensure that the quality of the equipment and local techniques was good and consistently high; system characterisation helped understand and where possible match the performance of the systems involved, whereas the imaging protocol was designed to allow a degree of flexibility to best match the characteristics of each imaging device.

Results

A total of 24 cameras on 15 sites from 8 different manufacturers were evaluated for inclusion in our multi-centre initiative. All results matched the required level of specification and each had their performance characterised. Differences in performance were found between different system types and cameras of the same type. Imaging protocols for each site were modified to match their individual characteristics to produce comparable high-quality SPECT images.

Conclusion

A framework has been designed to produce high-quality data for multi-centre SPECT studies. This framework has been successfully applied to a pan-European initiative to acquire a healthy control dopamine transporter image database.
Literatur
1.
Zurück zum Zitat Geworski L, Knoop BO, de Wit M, Ivancević V, Bares R, Munz DL. Multicenter comparison of calibration and cross calibration of PET scanners. J Nucl Med 2002;43(5):635–9.PubMed Geworski L, Knoop BO, de Wit M, Ivancević V, Bares R, Munz DL. Multicenter comparison of calibration and cross calibration of PET scanners. J Nucl Med 2002;43(5):635–9.PubMed
2.
Zurück zum Zitat McEwan AS, Graham MM, Conti PS. Site qualification in multicenter clinical trials. J Nucl Med 2009;50(8):30N.PubMed McEwan AS, Graham MM, Conti PS. Site qualification in multicenter clinical trials. J Nucl Med 2009;50(8):30N.PubMed
3.
Zurück zum Zitat Westerterp M, Pruim J, Oyen W, Hoekstra O, Paans A, Visser E, et al. Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters. Eur J Nucl Med Mol Imaging 2007;34(3):392–404.PubMedCrossRef Westerterp M, Pruim J, Oyen W, Hoekstra O, Paans A, Visser E, et al. Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters. Eur J Nucl Med Mol Imaging 2007;34(3):392–404.PubMedCrossRef
4.
Zurück zum Zitat Scheuermann JS, Saffer JR, Karp JS, Levering AM, Siegel BA. Qualification of PET scanners for use in multicenter cancer clinical trials: the American College of Radiology Imaging Network experience. J Nucl Med 2009;50(7):1187–93.PubMedCrossRef Scheuermann JS, Saffer JR, Karp JS, Levering AM, Siegel BA. Qualification of PET scanners for use in multicenter cancer clinical trials: the American College of Radiology Imaging Network experience. J Nucl Med 2009;50(7):1187–93.PubMedCrossRef
5.
Zurück zum Zitat Boellaard R, Oyen WJG, Hoekstra CJ, Hoekstra OS, Visser EP, Willemsen AT, et al. The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging 2008;35(12):2320–33.PubMedCrossRef Boellaard R, Oyen WJG, Hoekstra CJ, Hoekstra OS, Visser EP, Willemsen AT, et al. The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging 2008;35(12):2320–33.PubMedCrossRef
6.
Zurück zum Zitat Graham MM. The Clinical Trials Network of the Society of Nuclear Medicine. Semin Nucl Med 2010;40(5):327–31.PubMedCrossRef Graham MM. The Clinical Trials Network of the Society of Nuclear Medicine. Semin Nucl Med 2010;40(5):327–31.PubMedCrossRef
7.
Zurück zum Zitat McEwan AS, Graham MM, Conti PS. SNM molecular imaging summit introduces clinical trials network. J Nucl Med 2009;50(4):18N.PubMed McEwan AS, Graham MM, Conti PS. SNM molecular imaging summit introduces clinical trials network. J Nucl Med 2009;50(4):18N.PubMed
8.
Zurück zum Zitat Kadrmas DJ, Casey ME, Conti M, Jakoby BW, Lois C, Townsend DW. Impact of time-of-flight on PET tumor detection. J Nucl Med 2009;50(8):1315–23.PubMedCrossRef Kadrmas DJ, Casey ME, Conti M, Jakoby BW, Lois C, Townsend DW. Impact of time-of-flight on PET tumor detection. J Nucl Med 2009;50(8):1315–23.PubMedCrossRef
9.
Zurück zum Zitat Booij J, Tissingh G, Boer GJ, Speelman JD, Stoof JC, Janssen AG, et al. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson’s disease. J Neurol Neurosurg Psychiatry 1997;62(2):133–40.PubMedCrossRef Booij J, Tissingh G, Boer GJ, Speelman JD, Stoof JC, Janssen AG, et al. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson’s disease. J Neurol Neurosurg Psychiatry 1997;62(2):133–40.PubMedCrossRef
10.
Zurück zum Zitat McKeith I, O’Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 2007;6(4):305–13.PubMedCrossRef McKeith I, O’Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 2007;6(4):305–13.PubMedCrossRef
11.
Zurück zum Zitat Benamer TS, Patterson J, Grosset DG, Booij J, de Bruin K, van Royen E, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 2000;15(3):503–10.PubMedCrossRef Benamer TS, Patterson J, Grosset DG, Booij J, de Bruin K, van Royen E, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 2000;15(3):503–10.PubMedCrossRef
12.
Zurück zum Zitat Schneider SA, Edwards MJ, Mir P, Cordivari C, Hooker J, Dickson J, et al. Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs). Mov Disord 2007;22(15):2210–5.PubMedCrossRef Schneider SA, Edwards MJ, Mir P, Cordivari C, Hooker J, Dickson J, et al. Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs). Mov Disord 2007;22(15):2210–5.PubMedCrossRef
14.
Zurück zum Zitat IAEA. Chapter 8: SPECT systems. In: Quality control of nuclear medicine instrumentation. Vienna: IAEA; 1991. p. 253–300. IAEA. Chapter 8: SPECT systems. In: Quality control of nuclear medicine instrumentation. Vienna: IAEA; 1991. p. 253–300.
15.
Zurück zum Zitat Darcourt J, Booij J, Tatsch K, Varrone A, Vander Borght T, Kapucu OL, et al. EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging 2010;37(2):443–50.PubMedCrossRef Darcourt J, Booij J, Tatsch K, Varrone A, Vander Borght T, Kapucu OL, et al. EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging 2010;37(2):443–50.PubMedCrossRef
16.
Zurück zum Zitat Tossici-Bolt L, Dickson JC, Sera T, de Nijs R, Bagnara M, Jonsson C, et al. Calibration of gamma camera systems for a multicentre European (123)I-FP-CIT SPECT normal database. Eur J Nucl Med Mol Imaging 2011;38(8):1529–40.PubMedCrossRef Tossici-Bolt L, Dickson JC, Sera T, de Nijs R, Bagnara M, Jonsson C, et al. Calibration of gamma camera systems for a multicentre European (123)I-FP-CIT SPECT normal database. Eur J Nucl Med Mol Imaging 2011;38(8):1529–40.PubMedCrossRef
17.
Zurück zum Zitat Koch W, Radau PE, Hamann C, Tatsch K. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. J Nucl Med 2005;46(7):1109–18.PubMed Koch W, Radau PE, Hamann C, Tatsch K. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. J Nucl Med 2005;46(7):1109–18.PubMed
18.
Zurück zum Zitat Christian PE. Ensuring standardization and harmonization in multicenter clinical trials. J Nucl Med 2009;50(5):20N. Christian PE. Ensuring standardization and harmonization in multicenter clinical trials. J Nucl Med 2009;50(5):20N.
19.
Zurück zum Zitat Koch W, Radau PE, Münzing W, Tatsch K. Cross-camera comparison of SPECT measurements of a 3-D anthropomorphic basal ganglia phantom. Eur J Nucl Med Mol Imaging 2006;33(4):495–502.PubMedCrossRef Koch W, Radau PE, Münzing W, Tatsch K. Cross-camera comparison of SPECT measurements of a 3-D anthropomorphic basal ganglia phantom. Eur J Nucl Med Mol Imaging 2006;33(4):495–502.PubMedCrossRef
20.
Zurück zum Zitat Geworski L, Knoop BO, de Cabrejas ML, Knapp WH, Munz DL. Recovery correction for quantitation in emission tomography: a feasibility study. Eur J Nucl Med 2000;27(2):161–9.PubMedCrossRef Geworski L, Knoop BO, de Cabrejas ML, Knapp WH, Munz DL. Recovery correction for quantitation in emission tomography: a feasibility study. Eur J Nucl Med 2000;27(2):161–9.PubMedCrossRef
21.
Zurück zum Zitat Soret M, Koulibaly PM, Darcourt J, Hapdey S, Buvat I. Quantitative accuracy of dopaminergic neurotransmission imaging with (123)I SPECT. J Nucl Med 2003;44(7):1184–93.PubMed Soret M, Koulibaly PM, Darcourt J, Hapdey S, Buvat I. Quantitative accuracy of dopaminergic neurotransmission imaging with (123)I SPECT. J Nucl Med 2003;44(7):1184–93.PubMed
22.
Zurück zum Zitat Soret M, Koulibaly PM, Darcourt J, Buvat I. Partial volume effect correction in SPECT for striatal uptake measurements in patients with neurodegenerative diseases: impact upon patient classification. Eur J Nucl Med Mol Imaging 2006;33(9):1062–72.PubMedCrossRef Soret M, Koulibaly PM, Darcourt J, Buvat I. Partial volume effect correction in SPECT for striatal uptake measurements in patients with neurodegenerative diseases: impact upon patient classification. Eur J Nucl Med Mol Imaging 2006;33(9):1062–72.PubMedCrossRef
23.
Zurück zum Zitat Hutton BF, Lau YH. Application of distance-dependent resolution compensation and post-reconstruction filtering for myocardial SPECT. Phys Med Biol 1998;43(6):1679–93.PubMedCrossRef Hutton BF, Lau YH. Application of distance-dependent resolution compensation and post-reconstruction filtering for myocardial SPECT. Phys Med Biol 1998;43(6):1679–93.PubMedCrossRef
24.
Zurück zum Zitat Teo B, Seo Y, Bacharach SL, Carrasquillo JA, Libutti SK, Shukla H, et al. Partial-volume correction in PET: validation of an iterative postreconstruction method with phantom and patient data. J Nucl Med 2007;48(5):802–10.PubMed Teo B, Seo Y, Bacharach SL, Carrasquillo JA, Libutti SK, Shukla H, et al. Partial-volume correction in PET: validation of an iterative postreconstruction method with phantom and patient data. J Nucl Med 2007;48(5):802–10.PubMed
Metadaten
Titel
Proposal for the standardisation of multi-centre trials in nuclear medicine imaging: prerequisites for a European 123I-FP-CIT SPECT database
verfasst von
John Caddell Dickson
Livia Tossici-Bolt
Terez Sera
Robin de Nijs
Jan Booij
Maria Claudia Bagnara
Anita Seese
Pierre Malick Koulibaly
Umit Ozgur Akdemir
Cathrine Jonsson
Michel Koole
Maria Raith
Markus Nowak Lonsdale
Jean George
Felicia Zito
Klaus Tatsch
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 1/2012
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-011-1884-z

Weitere Artikel der Ausgabe 1/2012

European Journal of Nuclear Medicine and Molecular Imaging 1/2012 Zur Ausgabe